Forest Laboratories Completes Acquisition of Clinical Data
Forest Laboratories, Inc. (NYSE: FRX) today announced that it has successfully completed its acquisition of Clinical Data, Inc. (NASDAQ: CLDA) by means of what is known as a short-form merger under Delaware law.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.